Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models

View through CrossRef
Abstract Background: Inhibitory effect of endostar combined with radiotherapy on gastric cancer (GC) animal models and its effect on transforming growth factor-β (TGF-β)1 and inter- leukin-10 (IL-10) were evaluated.Methods: Forty mouse models of GC xenograft tumors were prepared and randomly divided into blank control group, endostar group, radiotherapy group and endostar combined with radiotherapy group (combina- tion group). From the 14th day, a vernier caliper was used for measuring the long and short diameters of the xenograft tumors. The formula V = ab2/2 was used for calculating the tumor volume and to obtain its average value. Tumor growth curves were plotted to calculate the tumor inhibition rate. The growth of xenograft tumors and the behavioral changes of mice were observed. ELISA was used for detecting the expression levels of IL-10 and TGF-β1.Results: The tumor growth in the combination group was significantly inhibited, and the tumor volume was finally the smallest compared with the other groups (p<0.05). Compared to the blank control group, the tumor inhibition rate was 11.8% in endostar group, 33.0% in radiotherapy group and 52.1% in combination group (p<0.01). Endostar combined with radiotherapy had an interaction in decreasing the expression levels of TGF-β1 and IL‑10 (F=4.35 and 5.12, p<0.05). Leucocyte count was significantly higher in control and combination groups than that in endostar and radiotherapy groups. The body weight of mice in endostar and radiotherapy groups decreased after treatment (p<0.05). The body weight of mice after treatment in control and combination groups increased, with a statistically significant difference compared to that before treatment (p<0.05). There was a statistically significant difference among all groups after treatment (F=198.1, p<0.01).Conclusions: Endostar combined with radiotherapy can inhibit tumor growth and downregulate the expression levels of TGF-β1 and IL-10 through synergistic action.
Springer Science and Business Media LLC
Title: Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models
Description:
Abstract Background: Inhibitory effect of endostar combined with radiotherapy on gastric cancer (GC) animal models and its effect on transforming growth factor-β (TGF-β)1 and inter- leukin-10 (IL-10) were evaluated.
Methods: Forty mouse models of GC xenograft tumors were prepared and randomly divided into blank control group, endostar group, radiotherapy group and endostar combined with radiotherapy group (combina- tion group).
From the 14th day, a vernier caliper was used for measuring the long and short diameters of the xenograft tumors.
The formula V = ab2/2 was used for calculating the tumor volume and to obtain its average value.
Tumor growth curves were plotted to calculate the tumor inhibition rate.
The growth of xenograft tumors and the behavioral changes of mice were observed.
ELISA was used for detecting the expression levels of IL-10 and TGF-β1.
Results: The tumor growth in the combination group was significantly inhibited, and the tumor volume was finally the smallest compared with the other groups (p<0.
05).
Compared to the blank control group, the tumor inhibition rate was 11.
8% in endostar group, 33.
0% in radiotherapy group and 52.
1% in combination group (p<0.
01).
Endostar combined with radiotherapy had an interaction in decreasing the expression levels of TGF-β1 and IL‑10 (F=4.
35 and 5.
12, p<0.
05).
Leucocyte count was significantly higher in control and combination groups than that in endostar and radiotherapy groups.
The body weight of mice in endostar and radiotherapy groups decreased after treatment (p<0.
05).
The body weight of mice after treatment in control and combination groups increased, with a statistically significant difference compared to that before treatment (p<0.
05).
There was a statistically significant difference among all groups after treatment (F=198.
1, p<0.
01).
Conclusions: Endostar combined with radiotherapy can inhibit tumor growth and downregulate the expression levels of TGF-β1 and IL-10 through synergistic action.

Related Results

The Preventive Effect of Endostar on Radiation-induced Pulmonary Fibrosis
The Preventive Effect of Endostar on Radiation-induced Pulmonary Fibrosis
Background: Radiation-induced pulmonary fibrosis (RIPF) is a long-term complication of thoracic radiotherapy without effective treatment available. Objective: This study aimed to...
Endostar Injection Inhibits Rabbit Ear Hypertrophic Scar Formation
Endostar Injection Inhibits Rabbit Ear Hypertrophic Scar Formation
This study aims to investigate the effect of Endostar injection on the rabbit ear hypertrophic scar formation and expand the use of Endostar. The rabbit ear hypertrophic scar model...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract Introduction Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
4060 Background: Gastric cancer is one of the most common cancer types. Most patients were diagnosed at advanced stages and experienced poor prognosis. A non-invasive assay for th...
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract Background: The associations of multiple autoimmune conditions with gastric cancer may reflect their co-occurrence with autoimmune gastritis and its clinica...
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
<div>Abstract<p>The hyaluronan-mediated motility receptor (HMMR) is overexpressed in gastric cancer; however, the apparent role of HMMR has not been well defined owing ...
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
<div>Abstract<p>The hyaluronan-mediated motility receptor (HMMR) is overexpressed in gastric cancer; however, the apparent role of HMMR has not been well defined owing ...

Back to Top